Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VH, Dupui M, Ingelman-Sundberg M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Mitropoulou C, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, Dávila Fajardo CL, Dolžan V, Patrinos GP, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ; Ubiquitous Pharmacogenomics Consortium. Swen JJ, et al. Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4. Lancet. 2023. PMID: 36739136 Clinical Trial.
Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes.
Haninger-Vacariu N, Gleiss A, Gaggl M, Aigner C, Kain R, Prohászka Z, Szilágyi Á, Csuka D, Böhmig GA, Sunder-Plassmann R, Sunder-Plassmann G, Schmidt A. Haninger-Vacariu N, et al. Among authors: sunder plassmann g. Kidney Med. 2023 May 16;5(7):100669. doi: 10.1016/j.xkme.2023.100669. eCollection 2023 Jul. Kidney Med. 2023. PMID: 37492116 Free PMC article.
Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design.
Daniel-Fischer L, Antlanger M, Cejka D, Eller K, Gauckler P, Odler B, Rudnicki M, Säemann MD, Schmidt A, Sunder-Plassmann G, Wiesholzer M, Windpessl M, Zitt E, Koenig F, Greenbaum LA, Kronbichler A, Aufricht C. Daniel-Fischer L, et al. Among authors: sunder plassmann g. Kidney Int Rep. 2023 Nov 3;9(2):478-481. doi: 10.1016/j.ekir.2023.10.027. eCollection 2024 Feb. Kidney Int Rep. 2023. PMID: 38344717 Free PMC article. No abstract available.
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy.
Tam FWK, Tumlin J, Barratt J, Rovin BH, Roberts ISD, Roufosse C, Cook HT, Bhangal G, Brown AL, Busch M, Dudhiya F, Duliege AM, Fraser DJ, Gale DP, Huang CC, Lai PC, Lee M, Masuda ES, McAdoo SP, Rosenkranz AR, Sommerer C, Sunder-Plassmann G, Szeto CC, Tang SCW, Williamson DE, Willcocks L, Vielhauer V, Kim MJ, Todd L, Zayed H, Tong-Starksen S, Lafayette R. Tam FWK, et al. Among authors: sunder plassmann g. Kidney Int Rep. 2023 Sep 30;8(12):2546-2556. doi: 10.1016/j.ekir.2023.09.024. eCollection 2023 Dec. Kidney Int Rep. 2023. PMID: 38106605 Free PMC article.
295 results